Manufacturer record
Upkar Pharmaceuticals - 101: regulatory record
Last checked 10 October 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Upkar Pharmaceuticals - 101 (Himachal Pradesh) were declared Not of Standard Quality between August 2026 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
1 record linked to Upkar Pharmaceuticals - 101 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Dicylomine Hydrochloride & Mefenamic Acid Tablets | UTA-25280Mfg 2026-04 · Exp 2028-03 | The sample does not conform to declared formula in respect of Identity test for Dicyclomine Hydrochlordie hence spuriousSpurious | LUCKNOW LABState lab | Aug 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.